Figure 4
Figure 4. Galectin-1 knockdown in MSCs resulted in a strongly reduced inhibition of IL-2/OKT3–stimulated PBMCs. (A) Proliferation of HLA-mismatched PBMCs in the absence or presence of MSCs. MSCwt and MSCcontr showed comparable inhibition of PBMC proliferation, whereas MSCG1▾ showed significantly reduced antiproliferative effects. (B) IFNγ-secretion by PBMCs measured 48 hours after stimulation with IL-2/OKT3 in the presence of HLA-mismatched MSCs. MSCG1▾ showed a significantly reduced inhibition of IFNγ secretion by PBMCs compared with MSCwt and MSCcontr. Data are shown as means (± SD) of quadruplicates (n = 3).

Galectin-1 knockdown in MSCs resulted in a strongly reduced inhibition of IL-2/OKT3–stimulated PBMCs. (A) Proliferation of HLA-mismatched PBMCs in the absence or presence of MSCs. MSCwt and MSCcontr showed comparable inhibition of PBMC proliferation, whereas MSCG1▾ showed significantly reduced antiproliferative effects. (B) IFNγ-secretion by PBMCs measured 48 hours after stimulation with IL-2/OKT3 in the presence of HLA-mismatched MSCs. MSCG1▾ showed a significantly reduced inhibition of IFNγ secretion by PBMCs compared with MSCwt and MSCcontr. Data are shown as means (± SD) of quadruplicates (n = 3).

Close Modal

or Create an Account

Close Modal
Close Modal